Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy
- PMID: 26786549
- PMCID: PMC5013876
- DOI: 10.1093/ndt/gfv445
Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy
Abstract
Apart from FGF23, the work by Leifheit-Nestler et al. provides welcome new insights into what role α-Klotho may have in cardiomyocyte hypertrophy.
Comment on
-
Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.Nephrol Dial Transplant. 2016 Jul;31(7):1088-99. doi: 10.1093/ndt/gfv421. Epub 2015 Dec 17. Nephrol Dial Transplant. 2016. PMID: 26681731 Free PMC article.
References
-
- Foley RN, Parfrey PS, Harnett JD et al. . Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186–192 - PubMed
-
- Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 2009; 4 (Suppl 1): S79–S91 - PubMed
-
- Gutierrez OM. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the ‘trade-off’ hypothesis. Clin J Am Soc Nephrol 2010; 5: 1710–1716 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
